TY - JOUR AU - Lau, E. AU - Salem, A. AU - Chan, J. C. N. AU - So, W. Y. AU - Kong, A. AU - Lamotte, M. AU - Luk, A. PY - 2019 DA - 2019/07/02 TI - Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis JO - Cost Effectiveness and Resource Allocation SP - 13 VL - 17 IS - 1 AB - International guidelines recommend using basal insulin in patients with type-2 diabetes mellitus if glycaemic target cannot be attained on non-insulin anti-diabetic drugs. Available choices of basal insulin include intermediate-acting neutral protamine Hagedorn (NPH) insulin and long-acting insulin analogues like insulin glargine U100. Despite clear advantages of glargine U100, the existing practice in Hong Kong still favours NPH insulin due to lower immediate drug costs. SN - 1478-7547 UR - https://doi.org/10.1186/s12962-019-0180-9 DO - 10.1186/s12962-019-0180-9 ID - Lau2019 ER -